Browsing by Author "Scheibner G"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemEveryday cognitive failures and memory compensation efforts: A selective optimization with compensation (SOC) Analysis(2013) Scheibner G; Leathem JMThe theory of Selective Optimization with Compensation (SOC) outlines how individuals may adapt more or less successfully to aging-related changes. Controlling for age, gender, education, and subjective health, the present study examined the relationships between cognitive failures and the SOC life management strategies. Results of this online survey (N = 409) indicated that SOC endorsement accounted for a significant reduction in each of the facets of the Cognitive Failures Questionnaire (i.e., forgetfulness, distractibility, and false triggering). Additional hypotheses tested whether mood may have a moderating effect on the beneficial effects of SOC, and whether SOC endorsement may moderate individual's efforts to compensate for perceived memory impairments. Results suggest that low mood attenuates the beneficial effects that SOC has on the frequency of cognitive failures. Counter to expectations, SOC endorsement did not affect the forgetfulness/memory compensation relationship. Results are discussed in view of methodological limitations and suggestions for future research are outlined.
- ItemThe midlife memory programme: A multiple case study evaluation of a group-based memory programme for healthy middle-aged individualsScheibner G; Leathem JMBackground • The literature shows that significant memory decline begins during midlife which is usually defined as the period of life between of 40-65 years of age. • 40 % of middle-aged people report everyday forgetfulness (Ponds, Commissaris, & Jolles, 1997). • More than half of these people perceive their forgetfulness as a hindrance in their daily live. • 70% of individuals in this age-group have expressed worries about their increasing forgetfulness (Commissaris, Ponds, & Jolles, 1998). • Memory interventions though are usually intended for individuals who are older than 65 years of age with mild to moderate memory impairment or for people with recognised neurological conditions such as TBI.